摘要
There is increasing incidence and prevalence of acute and chronic liver diseases(CLDs)all over the world which influence the quality of life and can give rise to life threatening complications.The burden of advanced liver disease due to hepatitis B has been controlled by antivirals but its eradication is difficult soon.Highly effective directly acting antiviral therapy has reduced the burden of hepatitis C but is partially offset by increasing IV drug abuse.Non-alcoholic fatty liver disease pandemic is on and there is recent alarming increase in alcohol related liver disease,both of which have no drug cure apart from control of the risk factors.Genetic factors have been identified in progression of all forms of CLD.Due to better management of complications of CLD,the life span of patients have increased spiking the number of hepatocellular carcinoma(HCC)and patients needing liver transplantation(LT).The present severe acute respiratory syndrome coronavirus pandemic has affected the outcome CLD including LT in addition to causing acute hepatitis.Better diagnostics and therapeutics are available for liver fibrosis,portal hypertension,HCC and post LT management and many drugs are under trial.The present review summarises the current scenario of the epidemiology and the advances in diagnosis and treatment of liver diseases including their complications like portal hypertension,HCC and LT.
